Sanofi (OTCMKTS:SNYNF) Sees Significant Growth in Short Interest
by Amy Steele · The Cerbat GemSanofi (OTCMKTS:SNYNF – Get Free Report) saw a large growth in short interest in the month of June. As of June 30th, there was short interest totaling 304,695 shares, a growth of 81.6% from the June 15th total of 167,782 shares. Based on an average daily trading volume, of 36,083 shares, the short-interest ratio is currently 8.4 days.
Sanofi Stock Performance
Sanofi stock opened at $87.00 on Friday. The company’s fifty day simple moving average is $86.32 and its 200-day simple moving average is $90.74. Sanofi has a 12 month low of $80.74 and a 12 month high of $106.34.
About Sanofi
Sanofi is a multinational biopharmaceutical company headquartered in Paris, France, specializing in the research, development and manufacturing of prescription medicines, vaccines and consumer healthcare products. With a strategic focus on specialty care, vaccines, and general medicines, Sanofi’s portfolio addresses a broad range of therapeutic areas, including diabetes, cardiovascular disease, oncology, immunology and rare diseases. The company operates through distinct business segments, each dedicated to advancing patient care through innovative therapies and preventive solutions.
In its pharmaceuticals segment, Sanofi develops and markets biologics and small molecules designed to treat chronic and acute conditions.
Featured Stories
- Five stocks we like better than Sanofi
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors